R. Schlienger

First name
R.
Middle name
G.
Last name
Schlienger
Meier, C. R., Schlienger, R. G., Kraenzlin, M. E., Schlegel, B., & Jick, H. (2000). HMG-CoA reductase inhibitors and the risk of fractures. Jama.
Schlienger, R. G., Haefeli, W. E., Jick, H., & Meier, C. R. (2001). Risk of cataract in patients treated with statins. Arch Intern Med.
Meier, C. R., Schlienger, R. G., & Jick, H. (2001). Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Br J Clin Pharmacol.
Meier, C. R., Krahenbuhl, S., Schlienger, R. G., & Jick, H. (2002). Association between body mass index and liver disorders: an epidemiological study. J Hepatol.
Schlienger, R. G., Jick, H., & Meier, C. R. (2002). Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction. Br J Clin Pharmacol.
Jick, S. S., Kaye, J. A., Vasilakis-Scaramozza, C., Rodriguez, L. A. G., Ruigomez, A., Meier, C. R., et al. (2003). Validity of the general practice research database. Pharmacotherapy.
Schlienger, R. G., Jick, S. S., & Meier, C. R. (2004). Inhaled corticosteroids and the risk of fractures in children and adolescents. Pediatrics.
Schlienger, R. G., Kraenzlin, M. E., Jick, S. S., & Meier, C. R. (2004). Use of beta-blockers and risk of fractures. Jama. http://doi.org/10.1001/jama.292.11.1326
Schlienger, R. G., Fischer, L. M., Jick, H., & Meier, C. R. (2004). Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Saf.
Fischer, L. M., Schlienger, R. G., Matter, C. M., Jick, H., & Meier, C. R. (2004). Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction. Arch Intern Med. http://doi.org/10.1001/archinte.164.22.2472